NASH: Emerging Diagnosis, Identification of Complications, and Evolving Treatment Strategies is organized by Global Academy for Medical Education, LLC. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credit™ / 1.0 contact hour.
This activity has been designed to address the educational needs of physicians in the field of gastroenterology and hepatology who are actively treating patients with nonalcoholic steatohepatitis (NASH). Primary care physicians, physician assistants, and nurse practitioners who are treating patients with NASH will also benefit.
Release date: Jun 30, 2019
Valid through: Jun 30, 2020.
At the conclusion of this program, participants should be better able to:
• Describe at least 2 factors contributing to the increasing prevalence of NAFLD/NASH
• Explain the process for screening for NAFLD/NASH in patients with metabolic risk factors
• Identify a practical stepwise approach to the evaluation of patients with suspected NAFLD/NASH that includes referral to hepatologists
• Describe a comprehensive management strategy for NAFLD/NASH that incorporates lifestyle strategies and approved therapeutic agents
• Discuss the mechanisms of action and trial data on emerging therapeutic agents for the management of NAFLD/NAS.
Additional details will be posted as soon as information is available.